Key result
Right ventricular free wall strain <23% was independently associated with all-cause mortality in CRT recipients (HR 1.618; 95% CI 1.252-2.092; p<0.001).
Why the study?
Measuring RV systolic function with echocardiography remains challenging due to complex right heart morphology, and whether RV free wall strain improves risk stratification in CRT recipients compared with conventional parameters is unclear.
Does right ventricular free wall strain improve prognostic risk stratification for all-cause mortality compared to conventional echocardiographic parameters in recipients of cardiac resynchronization therapy?
Cohort (n=871)
Does right ventricular free wall strain improve prognostic risk stratification for all-cause mortality compared to conventional echocardiographic parameters in recipients of cardiac resynchronization therapy?
Hazard Ratio: 1.618 (95% CI 1.252–2.092)
p-value: p=<0.001
Right ventricular free wall strain is more sensitive than conventional echocardiographic markers for detecting impaired RV function and provides incremental prognostic value for all-cause mortality in CRT recipients.
May support RV strain for mortality risk stratification in CRT; leaves open incremental value over conventional echo in prospective validation.
Right ventricular (RV) function is an important prognostic marker in cardiac resynchronization therapy (CRT) recipients. Measuring RV systolic function with echocardiography, however, remains challenging due to the complexity of right heart morphology. Evaluation of RV function with RV free wall strain (FWS) may improve risk stratification in recipients of CRT compared with conventional RV function parameters. In 871 recipients of CRT (mean age 65 ± 11 years, 75% were men), RV function was assessed by RV fractional area change (FAC), tricuspid annular plane systolic excursion (TAPSE), and RV FWS measured by speckle tracking echocardiography. RV dysfunction was defined as RV FWS <23%, RV FAC <35%, and TAPSE <17 mm according to present guidelines. Patients were followed up for the primary end point of all-cause mortality. RV FWS identified a higher percentage of patients with RV systolic dysfunction (80.6%) in comparison with RV FAC (44.1%) and TAPSE (60.6%). During a median follow-up of 97 (53 to 145) months, 521 patients (59.8%) died. Recipients of CRT with RV FWS <23% had higher event rates than those with RV FWS ≥23% (p <0.001). On multivariable analysis, RV FWS <23% was independently associated with all-cause mortality (hazard ratio 1.618; 95% confidence interval 1.252 to 2.092; p <0.001) and demonstrated incremental prognostic value over baseline clinical parameters as well as conventional RV function parameters. In conclusion, RV FWS is more sensitive than conventional echocardiographic markers of RV function in detecting impaired RV function. RV FWS is independently associated with all-cause mortality and demonstrates incremental prognostic value over conventional RV function parameters in recipients of CRT.
No takes yet. Share an insight, caveat, or question.
Stassen et al. (2022) conducted a cohort in Cardiac resynchronization therapy (CRT) recipients (n=871). Right ventricular free wall strain (FWS) <23% vs. RV FWS ≥23% was evaluated on All-cause mortality (HR 1.618, 95% CI 1.252 to 2.092, p=<0.001). Right ventricular free wall strain <23% was independently associated with all-cause mortality in CRT recipients (HR 1.618; 95% CI 1.252-2.092; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: